Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Gawlik (Katowice, Poland), G. Bochenek (Kraków, Poland), D. Brzostek (Warsaw, Poland), W. Barg (Wroclaw, Poland), G. Brozek (Katowice, Poland), P. Dabrowiecki (Warsaw, Poland), A. Dabrowski (Warsaw, Poland), R. Dobek (Warsaw, Poland), A. Kucharczyk (Warsaw, Poland), M. Kupczyk (Lódz, Poland), I. Kuprys-Lipinska (Lódz, Poland), A. Mastalerz-Migas (Wroclaw, Poland), M. Kowalski (Lódz, Poland). Late Breaking Abstract - Overestimation of asthma control and misperception of short-acting ß2-agonists (SABA) use among physicians in Poland. 958

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Overprescription of short-acting beta2-agonists in asthma management? Pharmacy reports from 91,673 patients in Poland Source: International Congress 2019 – New towards old therapies in airway diseases Year: 2019 Late Breaking Abstract - Impact of maintenance and reliever therapy (MART)-focused asthma guideline on SABA prescriptions Source: Virtual Congress 2021 – Highlights for primary care in 2021 Year: 2021 Late Breaking Abstract - Patterns of inhaled corticosteroid-formoterol prescriptions in Poland Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts Year: 2019 Late Breaking Abstract - Short-acting ß2-agonist use in asthma in Western societies Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma Year: 2020 Late Breaking Abstract - Difference in clinical outcomes between smoking and non-smoking asthma patients who initiated an ICS or ICS/LABA treatment Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies Year: 2019 Late Breaking Abstract - COPD exacerbation benefits relative to pneumonia risk with budesonide/glycopyrronium/formoterol metered dose inhaler: analyses from ETHOS Source: Virtual Congress 2020 – Advances in pharmacological treatment of COPD Year: 2020 Late Breaking Abstract - Cost effectiveness of as-needed budesonide/formoterol vs low-dose ICS maintenance therapy in mild asthma patients: A UK perspective Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness Year: 2019 Late Breaking Abstract - SABA overuse and risk of mortality in a nationwide Swedish asthma cohort (HERA) Source: International Congress 2019 – New towards old therapies in airway diseases Year: 2019 Predictors of excessive short-acting beta2-agonist use and asthma exacerbations: a retrospective analysis of a Polish prescription database. Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma Year: 2020 Pattern of asthma control and inhaled corticosteroid (ICS) use in an Australian asthma population Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease Year: 2013 Late Breaking Abstract - The burden of intermittent oral corticosteroid use in asthma Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science Year: 2021 Real-life asthma impairment: SABA use depends on smoking phenotype Source: Annual Congress 2013 –Treatment and management of asthma in primary care Year: 2013 Late Breaking Abstract - Assessment of physical functioning and handling with Tiotropium/Olodaterol (T/O) in patients with COPD requiring long-acting dual bronchodilation in an Italian cohort of patients. Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019 Identification of asthma level of control using administrative data of short-acting beta-agonist inhalers purchase Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 Late Breaking Abstract - Short-term and maintenance oral corticosteroid use for German patients with asthma Source: International Congress 2019 – Powerful cohort studies with/without lung function Year: 2019 Late Breaking Abstract - Identifying and addressing patient beliefs driving SABA use and over-reliance Source: International Congress 2019 – Novel findings from asthma clinical trials Year: 2019 Late Breaking Abstract - What do children, parents and paediatricians feel about the risk of growth suppression of inhaled corticosteroids? Source: International Congress 2018 – Paediatric asthma: new insights in its prevalence, treatment and treatment failure Year: 2018 Late Breaking Abstract - Factors associated with health-status of COPD patients on Dry Powder Inhaler (DPI) maintenance therapy Source: Virtual Congress 2021 – Highlights for primary care in 2021 Year: 2021 Late Breaking Abstract - The impact of the use of helmet CPAP in a general ward during COVID-19 outbreak Source: Virtual Congress 2020 – Covering COVID - the best abstracts Year: 2020 Late Breaking Abstract - Silent exacerbations: underreporting of COPD exacerbations in Poland Source: Virtual Congress 2020 – COPD and the impact of comorbidities Year: 2020